Si prevede che il mercato del monitoraggio cardiaco a distanza raggiungerà i 31.671,69 milioni di dollari entro il 2028 rispetto ai 4.976,40 milioni di dollari del 2021; si stima che crescerà a un CAGR del 30,3% dal 2021 al 2028.
I dispositivi di monitoraggio cardiaco a distanza consentono un monitoraggio continuo delle attività elettriche del cuore lontano dagli ospedali. Consentono inoltre il monitoraggio elettrocardiografico (ECG) domiciliare di pazienti con sospetta aritmia cardiaca o a rischio di sviluppare aritmie. Il monitoraggio può essere eseguito anche quando i pazienti sono impegnati nelle loro attività quotidiane. Pertanto, uno dei vantaggi più importanti del monitoraggio remoto dei dispositivi cardiaci è che riduce la necessità di visite mediche di routine. Dispositivi come pacemaker e defibrillatori cardiaci impiantabili vengono impiantati nel cuore dei pazienti attraverso procedure minimamente invasive. Un trasmettitore che funziona in sincronia con il dispositivo effettua la trasmissione dei dati. Fattori come l’aumento dell’incidenza delle malattie cardiovascolari (CVD) e i continui sviluppi nell’approccio della telemedicina stimolano la crescita del mercato del monitoraggio cardiaco a distanza. Tuttavia, le preoccupazioni relative alla privacy dei dati ostacolano la crescita del mercato.
Regioni redditizie per il mercato del monitoraggio cardiaco remotoMarket Insights
Aumento dell'incidenza delle malattie cardiovascolari
Il monitoraggio remoto dei pazienti (RPM) consente ai pazienti di gestire meglio la propria salute aumentando il loro coinvolgimento nella loro assistenza sanitaria. L’American Heart Association sostiene iniziative per incentivare la progettazione e l’uso di tecnologie di monitoraggio remoto dei pazienti basate sull’evidenza. Secondo l’Organizzazione Mondiale della Sanità (OMS), le malattie cardiovascolari (CVD) sono tra le principali cause di morte in tutto il mondo e ogni anno circa 30 milioni di persone sono colpite da ictus. Secondo l’American Heart Association, quasi la metà degli adulti negli Stati Uniti ha un tipo di malattia cardiovascolare. Inoltre, si prevede che più di 130 milioni di persone, ovvero il 45,1% della popolazione statunitense, avranno un tipo di malattia cardiovascolare entro il 2035. Secondo i rapporti della Società Europea di Cardiologia, le malattie cardiovascolari causano 3,9 milioni di morti in Europa e oltre 1,8 milioni di decessi nell’Unione Europea (UE). Inoltre, rappresentano il 45% di tutti i decessi in Europa e il 37% del totale dei decessi nell’UE. La mortalità causata da malattie cardiovascolari nei paesi dell’Asia-Pacifico varia da meno del 20% in paesi come Tailandia, Filippine e Indonesia al 20-30% nelle aree urbane di Cina, Hong Kong, Giappone, Corea e Malesia. Inoltre, Nuova Zelanda, Australia e Singapore, tra gli altri, presentano tassi relativamente elevati, pari al 30-35%.
L'ipertensione è un fattore di rischio significativo per le malattie cardiovascolari. La prevalenza dell’ipertensione aggiustata per età tra gli adulti negli Stati Uniti è pari a circa il 35%, pari a una popolazione di circa 85 milioni di persone. Entro il 2035, circa il 42% degli adulti del Paese, ovvero altri 27 milioni, soffrirebbero di questa condizione. Anche il peso dei costi dell’ipertensione sulle economie è in aumento, ed è probabile che i costi aumentino da circa 70 miliardi di dollari nel 2015 a circa 150 miliardi di dollari entro il 2035. Il monitoraggio remoto dei pazienti può fungere da canale vitale per migliorare il controllo dell’ipertensione e ridurre l’onere economico derivante da degenze ospedaliere prolungate o frequenti conseguenti ad eventi acuti correlati all’ipertensione. La ricerca ha dimostrato che l'RPM (monitoraggio remoto del paziente) può ridurre significativamente la pressione sanguigna sistolica (PAS) e la pressione sanguigna diastolica (DBP) rispetto alle cure abituali e all'automonitoraggio da soli. Secondo alcuni studi non randomizzati, i dispositivi RPM possono migliorare i risultati consentendo un rilevamento accurato e precoce e diminuendo i tassi di mortalità per tutte le cause e i ricoveri ospedalieri. Recenti linee guida cliniche raccomandano fortemente l'uso dell'RPM per il rilevamento della fibrillazione atriale (FA) sia nei pazienti colpiti da ictus che in quelli non colpiti da ictus.
Approfondimenti basati sul tipo di prodotto
In base al tipo di prodotto, il mercato del monitoraggio cardiaco remoto è ulteriormente segmentato in dispositivi, software e servizi. Il segmento dei dispositivi deteneva una quota di mercato maggiore nel 2021 e si prevede che registrerà un CAGR più elevato durante il periodo di previsione.
Mercato del monitoraggio cardiaco remoto, per tipo di prodotto: 2021 e 2028Approfondimenti basati sull'utente finale
In base all'utente finale, il mercato del monitoraggio cardiaco remoto è segmentato in ospedali e cliniche, strutture di emergenza, strutture di assistenza domiciliare e altri. Il segmento degli ospedali e delle cliniche deterrà la quota di mercato maggiore nel 2021, mentre si prevede che il mercato per il segmento delle strutture di emergenza crescerà a un CAGR del 31,60% durante il periodo di previsione.
Approfondimenti strategici
Varie aziende che operano nel mercato del monitoraggio cardiaco remoto stanno adottando strategie come lanci di prodotti, fusioni e acquisizioni, collaborazioni, innovazioni di prodotto ed espansioni del portafoglio prodotti per espandere la propria presenza in tutto il mondo, mantenere il marchio nome e soddisfare la crescente domanda da parte degli utenti finali.
Mercato del monitoraggio cardiaco remoto: per tipo di prodotto
- Dispositivi
- Software
- Servizi
Mercato del monitoraggio cardiaco remoto: per utente finale
- Ospedali e cliniche
- Impostazioni di emergenza
- Impostazioni di assistenza domiciliare
- Altro
Mercato del monitoraggio cardiaco remoto: per area geografica
- Nord America
- Stati Uniti
- Canada
- Messico
< li>Europa - Francia
- Germania
- Italia
- Regno Unito
- Spagna
- Resto dell'Europa
- Asia Pacifico (APAC)
- Cina
- India
- Corea del Sud
- Giappone
- Australia
- Resto dell'Asia Pacifico
- Medio Oriente e Asia Africa (MEA)
- Sudafrica
- Arabia Saudita
- Emirati Arabi Uniti
- Resto del Medio Oriente e dell'Africa. Africa
- Sud e Africa America Centrale (SCAM)
- Brasile
- Argentina
- Resto dell'America centrale e meridionale
- OSI Systems, Inc.
- GE Healthcare
- Biotronik Se
- Nihon Kohden Corporation
- Abbott Laboratories
- Boston Scientific Corporation
- Koninklijke Philips NV
- Honeywell International, Inc.
- AMC Health
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Remote cardiac monitoring is the constant monitoring of electrical activities of the heart, which practices place outside hospitals. The monitoring can also be performed while the patient is doing the day-to-day activities. Devices like pacemakers and implantable cardioverter-defibrillator are placed with the patient through minimally invasive procedures. The transmission of data takes place within a transmitter that works in sync with the device. Remote cardiac monitoring technologies allow home electrocardiographic (ECG) monitoring of patients with suspected cardiac arrhythmias or at risk for developing arrhythmias. One of the most important benefits of remote cardiac device monitoring is that it cuts down on routine doctor visits. Without remote monitoring, patients visited the doctor every three to six months (depending on device type) for a data download. With remote monitoring, the number of visits have dropped to one to two per year. Remote cardiac device monitoring is a fantastic way to follow patients and it has always been important, but it’s especially important in this era of COVID-19.
Key factors that are driving the growth of this market are increase in incidence of cardiovascular diseases, continuous developments in telemedicine approach, and rising investment in research and development are expected to boost the market growth for the remote cardiac monitoring over the years.
The device segment dominated the global remote cardiac monitoring market and held the largest revenue share of 58.53% in 2021.
The hospitals and clinics segment dominated the global remote cardiac monitoring market and accounted for the largest revenue share of 37.60% in 2021.
The remote cardiac monitoring market majorly consists of the players such OSI Systems, Inc., GE Healthcare, Biotronik Se, Nihon Kohden Corporation, Abbott Laboratories, Boston Scientific Corporation, Koninklijke Philips N.V., Honeywell International, Inc. and AMC Health among others.
Global remote cardiac monitoring market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for remote cardiac monitoring. The US is estimated to hold the largest share in the remote cardiac monitoring market during the forecast period. The growth of the market can be because of the rising investments in cardiology informatics, connected devices, and mobile solutions for advanced cardiac care, increasing product launches, and R&D activities to develop advanced remote cardiac monitoring devices. In addition, technologically advanced products are likely to stimulate the growth of remote cardiac monitoring market in North America. On the other hand, growing emphasis on cost optimization, focus on streamlining of clinical processes, increasing number of clinical trials, rise in the government initiatives, growing number of research and development activities, and rising number of product launches and approvals in the Asia Pacific is expected to account for the fastest growth of the region during the coming years.
The List of Companies - Remote Cardiac Monitoring Market
- OSI Systems, Inc.
- GE Healthcare
- Biotronik Se
- Nihon Kohden Corporation
- Abbott Laboratories
- Boston Scientific Corporation
- Koninklijke Philips N.V.
- Honeywell International, Inc.
- AMC Health
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Sep 2021
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Sep 2021
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2021
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Sep 2021
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)